• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Analysis of the clinical features and prognostic influencing factors of toxic epidermal necrolysis].中毒性表皮坏死松解症的临床特征及预后影响因素分析
Zhonghua Shao Shang Za Zhi. 2021 Aug 20;37(8):738-746. doi: 10.3760/cma.j.cn501120-20200416-00230.
2
[Epidemiological characteristics and risk factors of sepsis development and death in patients with extremely severe burns].[特重度烧伤患者脓毒症发生及死亡的流行病学特征与危险因素]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Jun 20;39(6):558-564. doi: 10.3760/cma.j.cn501225-20220806-00336.
3
[Analysis of clinical characteristics and risk factors of death in critical burn patients complicated with invasive fungal infection].[重症烧伤合并侵袭性真菌感染患者临床特征及死亡危险因素分析]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Jul 20;39(7):618-624. doi: 10.3760/cma.j.cn501225-20230415-00127.
4
[Predictive values of serum 8-hydroxydeoxyguanosine on disease progression and prognosis of patients with sepsis].血清8-羟基脱氧鸟苷对脓毒症患者疾病进展及预后的预测价值
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Mar 20;38(3):207-214. doi: 10.3760/cma.j.cn501120-20210910-00311.
5
[Clinical characteristics of 11 patients with infection and the establishment of a rapid diagnosis procedure for this disease].11例[疾病名称]感染患者的临床特征及该疾病快速诊断程序的建立
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):266-272. doi: 10.3760/cma.j.cn501225-20230803-00036.
6
[Establishment and validation of a risk prediction model for disseminated intravascular coagulation patients with electrical burns].[电烧伤并发弥散性血管内凝血患者风险预测模型的建立与验证]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Aug 20;39(8):738-745. doi: 10.3760/cma.j.cn501225-20230419-00132.
7
[Multicenter retrospect analysis of early clinical features and analysis of risk factors on prognosis of elderly patients with severe burns].老年重度烧伤患者早期临床特征的多中心回顾性分析及预后危险因素分析
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):249-257. doi: 10.3760/cma.j.cn501225-20230808-00042.
8
[Analysis of the clinical characteristics and risk factors of postoperative atrial fibrillation in patients with critical burns].[重症烧伤患者术后心房颤动的临床特征及危险因素分析]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 May 20;38(5):408-414. doi: 10.3760/cma.j.cn501225-20220214-00026.
9
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.对来自中国的213例史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
10
[Establishment of an early risk prediction model for bloodstream infection and analysis of its predictive value in patients with extremely severe burns].[建立血流感染早期风险预测模型并分析其在特重度烧伤患者中的预测价值]
Zhonghua Shao Shang Za Zhi. 2021 Jun 20;37(6):530-537. doi: 10.3760/cma.j.cn501120-20210114-00021.

本文引用的文献

1
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症管理与认识的最新进展
F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.
2
Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:全面综述。
Adv Wound Care (New Rochelle). 2020 Jul;9(7):426-439. doi: 10.1089/wound.2019.0977. Epub 2020 Jan 9.
3
Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.多形红斑、史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症 - 诊断和治疗。
J Dtsch Dermatol Ges. 2020 Jun;18(6):547-553. doi: 10.1111/ddg.14118. Epub 2020 May 29.
4
Case of toxic epidermal necrolysis successfully treated with repeated i.v. immunoglobulin.
J Dermatol. 2020 Jul;47(7):e265-e266. doi: 10.1111/1346-8138.15356. Epub 2020 Apr 24.
5
Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:危险因素、因果关系评估和潜在的预防策略。
Expert Rev Clin Immunol. 2020 Apr;16(4):373-387. doi: 10.1080/1744666X.2020.1740591. Epub 2020 Apr 2.
6
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.对来自中国的213例史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
7
Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患儿的临床特征、结局及治疗
Acta Biomed. 2019 Jan 29;90(3-S):52-60. doi: 10.23750/abm.v90i3-S.8165.
8
British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018.英国皮肤科医师协会《2018年儿童和青少年史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症管理指南》
Br J Dermatol. 2019 Jul;181(1):37-54. doi: 10.1111/bjd.17841. Epub 2019 Apr 25.
9
How Does SCORTEN Score?SCORTEN评分是如何计算的?
J Burn Care Res. 2018 Jun 13;39(4):555-561. doi: 10.1093/jbcr/irx016.
10
Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症;药物诱发病因报告及可能治疗方式的广泛综述
Open Access Maced J Med Sci. 2018 Mar 28;6(4):730-738. doi: 10.3889/oamjms.2018.148. eCollection 2018 Apr 15.

中毒性表皮坏死松解症的临床特征及预后影响因素分析

[Analysis of the clinical features and prognostic influencing factors of toxic epidermal necrolysis].

作者信息

Hu Z X, Bian H N, Ma D, Luo H M, Sun C W, Lai W

机构信息

Surgery Ward 2, Zhuhai Golden Bay Center Hospital, Zhuhai 519040, China.

Department of Burns and Wound Repair, Guangdong Provincial People's Hospital, Guangzhou 510080, China.

出版信息

Zhonghua Shao Shang Za Zhi. 2021 Aug 20;37(8):738-746. doi: 10.3760/cma.j.cn501120-20200416-00230.

DOI:10.3760/cma.j.cn501120-20200416-00230
PMID:34404158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11917252/
Abstract

To investigate the clinical features and prognostic influencing factors of toxic epidermal necrolysis (TEN). A retrospective observational study was conducted. From January 2008 to March 2019, a total of 46 TEN patients who met the inclusion criteria were admitted to Guangdong Provincial People's Hospital. The gender, age, and hospital admission diagnosis of the 46 patients, the category of department admitted of patients complicated with sepsis, death ratio of the sepsis patients with or without treatment history in intensive care unit (ICU)/department of burns and wound repair, and the cause of death of the deceased patients were recorded. Depending on whether complicated with sepsis, the patients were divided into sepsis group (32 cases) and non-sepsis group (14 cases). According to whether died or not, the patients were divided into death group (9 cases) and survival group (37 cases). The specific conditions of suspected pathogenic agents and combined underlying diseases, the abnormality of transaminase/bilirubin, creatinine, and platelet count in blood on admission, and the detection of pathogenic microorganisms and drug resistance during the course of disease of patients were recorded in both sepsis group and non-sepsis group. The gender, age, lesion area, severity of illness score for TEN (SCORTEN) system score, combined underlying diseases on admission, and blood microbial culture positivity, hormone use, and gamma globulin use during the course of disease of patients between sepsis group and non-sepsis group, death group and survival group were compared respectively. Data were statistically analyzed with chi-square test, Fisher's exact probability test, and Mann-Whitney test. The factors with statistically significant differences between sepsis group and non-sepsis group, death group and survival group were selected for binary multivariate logistic regression analysis, so as to screen the independent risk factors affecting sepsis and death in TEN patients. Of the 46 TEN patients, 30 were male and 16 were female, aged from 8 months to 92.0 years, with 11 cases (23.91%) of epidermolysis bullosa, 9 cases (19.57%) of exfoliative dermatitis, 9 cases (19.57%) of TEN, 7 cases (15.22%) of epidermolysis bullosa, 6 cases (13.04%) of Stevens-Johnson syndrome, and 4 cases (8.70%) of severe drug rash for hospital admission diagnosis. The patients complicated with sepsis were admitted to 11 departments, and the death ratio of patients with treatment history in ICU/department of burns and wound repair was similar to that of patients without such department treatment history (>0.05). All the deceased patients were complicated with sepsis, which was also the main cause of death. On admission, the suspected pathogenic agents of patients in sepsis group were mainly allopurinol (8 cases) and non-steroidal anti-inflammatory drugs (4 cases), while those in non-sepsis group were allopurinol (3 cases) and psychotropic drugs (3 cases). Patients in sepsis group combined as many as 10 underlying diseases, while those in non-sepsis group combined only 4 underlying diseases. The proportions of patients with increased creatinine (=13.349, <0.01) and decreased platelet count (<0.01) in sepsis group were significantly higher than those in non-sepsis group, while the transaminase/bilirubin abnormality was similar to that in non-sepsis group (>0.05). A wide variety of pathogens were detected in the blood, respiratory tract secretions, and skin secretions of 21 patients in sepsis group, and 14 patients were infected with drug-resistant bacteria; among the 9 strains cultured from the blood samples, 8 were drug-resistant bacteria and 6 were Gram-positive bacteria. In non-sepsis group, pathogens were detected in blood, respiratory tract secretions, and skin secretions of 8 patients, with fewer species, and 6 patients were infected with drug-resistant bacteria. The gender, age, lesion area, blood microbial culture positivity, hormone use, and gamma globulin use of patients in sepsis group were similar to those in non-sepsis group (>0.05). The proportion of patients combined with underlying diseases (=4.493, <0.05) and the proportion of patients with SCORTEN system score of 4-6 points (<0.01) of patients in sepsis group were significantly higher than those in non-sepsis group. The gender, combined underlying diseases, lesion area, blood microbial culture positivity, hormone use, and gamma globulin use of patients were similar between survival group and death group (>0.05). The proportion of patients with age≥60 years and the proportion of patients with SCORTEN system score of 4-6 points of patients in death group were significantly higher than those in survival group (=4.412, 11.627, <0.05 or <0.01). The SCORTEN system score was an independent risk factor affecting sepsis and death in TEN patients (odds ratio=3.025, 2.757, 95% confidence interval=1.352-6.769, 1.244-6.110, <0.05 or <0.01). The diagnosis of TEN is difficult on admission. Male population is susceptible to TEN, and allopurinol is the common pathogenic agent. The proportion of patients combined with underlying diseases is high in TEN patients complicated with sepsis, with mainly drug-resistant bacteria and mostly Gram-positive bacteria in blood-borne infections. The deceased patients are older than the survived, and the main cause of death is sepsis. The SCORTEN system score is an independent risk factor affecting sepsis and death in TEN patients.

摘要

探讨中毒性表皮坏死松解症(TEN)的临床特征及预后影响因素。进行一项回顾性观察研究。2008年1月至2019年3月,广东省人民医院共收治46例符合纳入标准的TEN患者。记录46例患者的性别、年龄、入院诊断,合并脓毒症患者的收治科室类别,在重症监护病房(ICU)/烧伤与创面修复科有无治疗史的脓毒症患者的死亡率,以及死亡患者的死亡原因。根据是否合并脓毒症,将患者分为脓毒症组(32例)和非脓毒症组(14例)。根据是否死亡,将患者分为死亡组(9例)和存活组(37例)。记录脓毒症组和非脓毒症组疑似病原体及合并基础疾病的具体情况、入院时血液中转氨酶/胆红素、肌酐及血小板计数的异常情况,以及患者病程中病原微生物检测及耐药情况。分别比较脓毒症组与非脓毒症组、死亡组与存活组患者的性别、年龄、皮损面积、TEN疾病严重程度评分(SCORTEN)系统评分、入院时合并基础疾病情况,以及病程中血液微生物培养阳性情况、激素使用情况和丙种球蛋白使用情况。采用卡方检验(chi-square test)、Fisher确切概率检验(Fisher's exact probability test)和Mann-Whitney检验进行统计学分析。选取脓毒症组与非脓毒症组、死亡组与存活组间差异有统计学意义的因素进行二元多因素logistic回归分析,以筛选影响TEN患者发生脓毒症及死亡的独立危险因素。46例TEN患者中,男性30例,女性16例,年龄8个月至92.0岁,入院诊断为大疱性表皮松解症11例(23.91%)、剥脱性皮炎9例(19.57%)、TEN 9例(19.57%)、大疱性表皮松解型药疹(EBS)7例(15.22%)、史蒂文斯-约翰逊综合征(Stevens-Johnson syndrome,SJS)6例(13.04%)、重症药疹4例(8.70%)。合并脓毒症的患者分属11个科室,在ICU/烧伤与创面修复科有治疗史患者的死亡率与无该科室治疗史患者相似(>0.05)。所有死亡患者均合并脓毒症,脓毒症也是主要死亡原因。入院时,脓毒症组患者疑似病原体主要为别嘌醇(8例)和非甾体类抗炎药(4例),非脓毒症组为别嘌醇(3例)和精神类药物(3例)。脓毒症组患者合并基础疾病多达10种,非脓毒症组仅4种。脓毒症组患者肌酐升高(=13.349,<0.01)及血小板计数降低(<0.01)的比例显著高于非脓毒症组,而转氨酶/胆红素异常情况与非脓毒症组相似(>0.05)。脓毒症组21例患者的血液、呼吸道分泌物及皮肤分泌物中检测出多种病原体,14例患者感染耐药菌;血标本培养出的9株菌中,8株为耐药菌,6株为革兰阳性菌。非脓毒症组8例患者的血液、呼吸道分泌物及皮肤分泌物中检测出病原体,种类较少,6例患者感染耐药菌。脓毒症组患者的性别、年龄、皮损面积、血液微生物培养阳性情况、激素使用情况和丙种球蛋白使用情况与非脓毒症组相似(>s0.05)。脓毒症组患者合并基础疾病的比例(=s4.493,<0.05)及SCORTEN系统评分为4 - 6分患者的比例(<0.01)显著高于非脓毒症组s。存活组与死亡组患者的性别、合并基础疾病情况、皮损面积、血液微生物培养阳性情况、激素使用情况和丙种球蛋白使用情况相似(>0.05)。死亡组患者年龄≥60岁的比例及SCORTEN系统评分为4 - 6分患者的比例显著高于存活组(=4.412,11.627,<0.0s5或<0.01)。SCORTEN系统评分是影响TEN患者发生脓毒症及死亡的独立危险因素(比值比=3.025,2.757,95%置信区间=1.352 - 6.769,1.244 - 6.110,<0.05或<0.01)。TEN入院时诊断困难。男性人群易患TEN,别嘌醇是常见病原体。合并脓毒症的TEN患者合并基础疾病比例高,血行感染主要为耐药菌且多为革兰阳性菌。死亡患者年龄大于存活患者,主要死亡原因是脓毒症。SCORTEN系统评分是影响TEN患者发生脓毒症及死亡的独立危险因素。